Clinical impact of B-cell depletion with the anti-CD20 antibody rituximab in chronic fatigue syndrome: a preliminary case series

BACKGROUND: Chronic fatigue syndrome (CFS) is a disease of unknown aetiology. A patient with CFS had unexpected, marked recovery of CFS symptoms lasting for five months during and after cytotoxic chemotherapy for Hodgkin's disease. We reasoned that the transient CFS recovery was related to meth...

Descripción completa

Detalles Bibliográficos
Autores principales: Fluge, Øystein, Mella, Olav
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2711959/
https://www.ncbi.nlm.nih.gov/pubmed/19566965
http://dx.doi.org/10.1186/1471-2377-9-28

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2711959/
https://www.ncbi.nlm.nih.gov/pubmed/19566965
http://dx.doi.org/10.1186/1471-2377-9-28

Ejemplares similares